Profitability Ratios
| Ratio |
Value |
| GP Margin |
100.0% |
| EBIT Margin |
-87.3% |
| EBITDA Margin |
-76.8% |
| Operating Margin |
-87.3% |
| Pretax Margin |
-75.3% |
| Cont. Ops Margin |
-76.6% |
| Net Margin |
-76.6% |
| Bottom Line Margin |
-76.7% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
5.52 |
| Quick Ratio |
5.52 |
| Solvency Ratio |
-0.897 |
| Cash Ratio |
0.97 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.73 |
| Forward PEG |
0.73 |
| Price/Book |
7.39 |
| Price/Sales |
18.72 |
| Price/FCF |
-57.45 |
| Price/Op Cash Flow |
-60.10 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0527 |
| Debt/Equity |
0.0680 |
| Debt/Capital |
0.0637 |
| Long-Term Debt/Capital |
0.0000 |
| Financial Leverage |
1.29 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.53 |
| Operating Cash Flow Ratio |
-0.780 |
| Operating Cash Flow/Sales |
-31.1% |
| Free Cash Flow/Operating Cash Flow |
104.6% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-23.86 |
| Interest Coverage |
0.0000 |
| Short-Term Operating Cash Flow Coverage |
-9.51 |
| Operating Cash Flow Coverage |
-1.81 |
| Capital Expenditure Coverage |
-21.70 |
| Dividend + Capital Expenditure Coverage |
-21.70 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
1.41 |
| EPS |
-1.077 |
| Debt/Share |
0.2425 |
| Cash/Share |
3.04 |
| Book Value/Share |
3.56 |
| Tangible BV/Share |
-173.85 |
| Equity/Share |
3.56 |
| Operating Cash Flow/Share |
-0.438 |
| Capital Expenditure/Share |
0.020 |
| FCF/Share |
-0.458 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.017 |
| Earnings Before Tax/EBIT |
0.862 |
| Price/Fair Value |
7.39 |
| Debt/Market Cap |
0.0017 |
| Effective Tax Rate |
-1.7% |
| Enterprise Value Multiple |
-24.08 |
ZYME - Zymeworks Inc.